Package 71610-032-60

Brand: divalproex sodium

Generic: divalproex sodium
NDC Package

Package Facts

Identity

Package NDC 71610-032-60
Digits Only 7161003260
Product NDC 71610-032
Product ID 71610-032_a117c85f-4dfb-46da-99aa-4c4146e78865
Description

90 TABLET, DELAYED RELEASE in 1 BOTTLE (71610-032-60)

Marketing

Marketing Status
Marketed Since 2018-01-19
Brand divalproex sodium
Generic divalproex sodium
Sample Package No

Linked Drug Pages (1)

Divalproex Sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a117c85f-4dfb-46da-99aa-4c4146e78865", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099870"], "spl_set_id": ["9cfdcb58-d6d7-43bb-b6e1-17172b143296"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, DELAYED RELEASE in 1 BOTTLE (71610-032-53)", "package_ndc": "71610-032-53", "marketing_start_date": "20180119"}, {"sample": false, "description": "90 TABLET, DELAYED RELEASE in 1 BOTTLE (71610-032-60)", "package_ndc": "71610-032-60", "marketing_start_date": "20180119"}], "brand_name": "Divalproex Sodium", "product_id": "71610-032_a117c85f-4dfb-46da-99aa-4c4146e78865", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "71610-032", "generic_name": "Divalproex Sodium", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex Sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "500 mg/1"}], "application_number": "ANDA078182", "marketing_category": "ANDA", "marketing_start_date": "20140321", "listing_expiration_date": "20261231"}